Reduction of left ventricular mass index with blood pressure reduction in chronic renal failure

Clinical Nephrology

Volumn 52, Issue 6, 1999, Pages 377-382

  Tucker, B ^a   Fabbian, F ^b   Giles, M ^a   Johnston, A ^a   Baker, L R I ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b Department of Cardiology ^*  (Italy)

Author keywords

Ambulatory blood pressure (ABP); Anemia; Chronic renal failure (CRF); Hypertension; Left ventricular hypertrophy (LVH)

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; RECEPTOR BLOCKING AGENT;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; BODY MASS; CHRONIC KIDNEY FAILURE; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEMOGLOBIN DETERMINATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; SEX;

EID: 0032737719     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Canella G, Paoletti E, Delfino R, Peloso G, Molinari S, Traverso GB 1993 Regression of left ventricular hypertrophy in hypertensive dialyzed uremic patients on long-term antihypertensive therapy. Kidney Int 44: 881-886
2. Devereux RB, Alonso DR, Lutas EM et al 1986 Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57: 450-458
3. Devereux RB, de Simone G, Ganau A, Roman MJ 1994 Left ventricular hypertrophy and geometric remodelling in hypertension: stimuli, functional consequences and prognostic implications. J Hypertens 12 (Suppl 10): 117-127
4. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE 1996 Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int 49: 1379-1385
5. Gardner MJ, Altman DG 1986 Confidence intervals rather than P values: estimation rather than hypothesis testing. BMJ 292: 746-750
6. Gottdiener JS, Reda DJ, Massie BM, Materson BJ, Williams DW, Anderson RJ For the VA Co-operative Study Group on Antihypertensive Agents 1997 Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension. Comparison of six antihypertensive agents. Circulation 95: 2007-2014
7. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP 1990 Prognostic implications of echocardiography determined left ventricular mass in the Framingham heart study. N Engl J Med 322: 1561-1566
8. London GM, Pannier B, Guerin AP, Marchais SJ, Safar ME, Cuche JL 1994 Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease. Comparative effects of ACE inhibition and calcium channel blockade. Circulation 90: 2786-2796
9. Silberberg JS, Barre PE, Prichard SS, Sniderman AD 1989 Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 36: 286-290
10. Silberberg JS, Racine N, Barre PE, Sniderman AD 1990 Regression of left ventricular hypertrophy in dialysis patients following correction of anemia with recombinant human erythropoietin. Can J Cardiol 6: 1-4
11. Tucker B, Fabbian F, Giles M, Thuraisingham RC, Raine AEG, Baker LRI 1997 Left ventricular hypertrophy and ambulatory blood pressure monitoring in chronic renal failure. Nephrol Dial Transplant 12: 724-728
12. Zehnder C, Zuber M, Sulzer M, Meyer B, Straumann E, Jenzer HR, Blumberg A 1992 Influence of long-term amelioration of anaemia and blood pressure control on left ventricular hypertrophy in hemodialyzed patients. Nephron 61: 21-25